Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases – Co-led by New Investors, Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek – Cambr - Vertex - Document - PDFSEARCH.IO

First Page	Meta Content
	Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases – Co-led by New Investors, Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek – Cambr Add to Reading List Document Date: 2017-10-03 19:39:44 Open Document File Size: 26,75 KB Share Result on Facebook

Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases – Co-led by New Investors, Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek – CambrAdd to Reading List